For well-dressed wounds

The true cost of wound care

86% of the total cost of wound care results from managing infections, maceration, pain and anxiety, delayed healing, and the additional nursing and hospital resources these complications consume.1 Only 14% is from dressing acquisition.1

A premium-quality range can minimise complications and the larger cost of overall wound care. But can it answer your concerns about acquisition costs, too?

Well-dressed, on a budget

The real value of a quality wound care product is seeing a patient quickly respond to treatment and discharged from care early.

With a wound care range designed to achieve best outcomes, at the right price, Mölnlycke Health Care helps you achieve this at a lower total treatment cost than competitors.2

Modelled health economic impact (total treatment cost) for 1000 patients receiving active treatment for a month2-3*

Modelled health eonomic impact (total treatment cost) for 1000 patients in a month

*Treatment costs modelled using personal Social Services Research Unit data (2015) for labour times. Drug Tariff prices compared as of August 2016. Mölnlycke Health Care products Drug Tariff prices as of 1st October 2016 and Mepilex Border 10x10.5 (£1.90) as of January 2017. Nearest comparable sizes used. Total fluid handling data from SMTL reports. Standard wear times assumed across all products wound contact layers.

It means you can offer patients a quality product, whilst continuing to manage cost pressures. Can you afford to use anything else?

References

  1. Guest JF et al. BMJ Open. 2015;5 (12): e009283
  2. Data on file. 20160823 Budget Impact Model.
  3. SMTL fluid handling capacity report 10/3299/1.
  4. SMTL fluid handling capacity report 15/4962/1.
  5.  SMTL fluid handling capacity report 15/4863/1.
Share this